Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Sep 1;23(9):e429-e433.
doi: 10.1097/PCC.0000000000002993. Epub 2022 May 17.

Semiautomated Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy: An Observational Study in Young Children

Affiliations
Observational Study

Semiautomated Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy: An Observational Study in Young Children

Jean-Michel Liet et al. Pediatr Crit Care Med. .

Abstract

Objectives: To review use of semiautomated regional citrate anticoagulation (saRCA) for continuous kidney replacement therapy (CKRT) in young children.

Design: Retrospective cohort study.

Setting: Three independent PICUs.

Patients: All consecutive children weighing less than 11 kg who received CKRT with saRCA from January 2015 to June 2020.

Interventions: None.

Measurements and main results: Twenty-one children weighing less than 11 kg underwent CKRT with saRCA. The total duration of the CKRT was 2,014 hours, with a total of 64 CKRT sessions. Citrate intoxication occurred in four of 64 CKRT sessions (6%). Citrate intoxication was consistently observed in the few CKRT sessions where the initial lactate concentration was greater than 4 mmol/L or the ratio of replacement fluid flow to citrate flow less than 50%. The rate of unscheduled interruptions of CKRT sessions was 25% (16/64).

Conclusions: We have used saRCA for CKRT in children weighing less than 11 kg. A strict protocol and intensive training are required to minimize complications.

PubMed Disclaimer

Conflict of interest statement

The authors have disclosed that they do not have any potential conflicts of interest.

References

    1. Davis TK, Neumayr T, Geile K, et al.: Citrate anticoagulation during continuous renal replacement therapy in pediatric critical care. Pediatr Crit Care Med 2014; 15:471–485
    1. Monchi M, Berghmans D, Ledoux D, et al.: Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med 2004; 30:260–265
    1. Kutsogiannis DJ, Gibney RT, Stollery D, et al.: Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005; 67:2361–2367
    1. Raymakers-Janssen PAMA, Lilien M, van Kessel IA, et al.: Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children. Pediatr Nephrol 2017; 32:1971–1978
    1. Stucker F, Ponte B, Tataw J, et al.: Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: A randomized controlled trial. Crit Care 2015; 19:91

Publication types

LinkOut - more resources